Triumeq Evrópusambandið - íslenska - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Wellbutrin Retard (Lyfjaver) Tafla með breyttan losunarhraða 150 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

wellbutrin retard (lyfjaver) tafla með breyttan losunarhraða 150 mg

lyfjaver ehf. - bupropionum inn hýdróklóríð - tafla með breyttan losunarhraða - 150 mg

Lamictal Tuggu-/dreifitafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 50 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 50 mg

Lamictal Tuggu-/dreifitafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 5 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 5 mg

Lamictal Tuggu-/dreifitafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 25 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 25 mg

Lamictal Tuggu-/dreifitafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 200 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg

Lamictal Tuggu-/dreifitafla 2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 2 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 2 mg

Lamictal Tuggu-/dreifitafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 100 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 100 mg

Seretide Innúðalyf, dreifa 25/250 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seretide innúðalyf, dreifa 25/250 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innúðalyf, dreifa - 25/250 míkróg/skammt